TY - JOUR
T1 - Epidemiological studies regarding hypertensive disorders of pregnancy
T2 - A review
AU - Iwama, Noriyuki
AU - Ishikuro, Mami
AU - Tanaka, Kosuke
AU - Satoh, Michihiro
AU - Murakami, Takahisa
AU - Metoki, Hirohito
N1 - Funding Information:
HM concurrently holds the sub‐directorship at the Tohoku Institute for Management of Blood Pressure, which is supported by Omron Healthcare Co. Ltd, and is involved in collaborative research with Omron Healthcare in another study. Omron Healthcare Co. Ltd. was not involved in the study design, paper methodology, writing, or drafting of the paper or its conclusions. The authors have no other conflicts of interest to declare.
Funding Information:
This article was supported by Grants for Scientific Research (18590587, 18390192, 21390201, 24689061, 25253059, 26860412, 16H05243, 17 K15857, 18 K15837, 19H03905, JP19K18659 and 19 K18628) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant-in-Aid (19DA1001) for Health Research on Children, Youth and Families, and (H21-Junkankitou [Seishuu]-Ippan-004) from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan; Grant (JP19gk0110039) from AMED; and a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (19.7152, 20.7198, 20.7477 and 20.54043). There were also Academic Contributions from Pfizer Japan Inc.; Bayer Academic Support; Takeda Research Support; Astellas Research Support; Scholarship donations from Chugai Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Daiichi Sankyo Co., Ltd. We would like to thank Editage (www.editage.com) for English language editing.
Funding Information:
This article was supported by Grants for Scientific Research (18590587, 18390192, 21390201, 24689061, 25253059, 26860412, 16H05243, 17 K15857, 18 K15837, 19H03905, JP19K18659 and 19 K18628) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant‐in‐Aid (19DA1001) for Health Research on Children, Youth and Families, and (H21‐Junkankitou [Seishuu]‐Ippan‐004) from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan; Grant (JP19gk0110039) from AMED; and a Grant‐in‐Aid for Japan Society for the Promotion of Science (JSPS) fellows (19.7152, 20.7198, 20.7477 and 20.54043). There were also Academic Contributions from Pfizer Japan Inc.; Bayer Academic Support; Takeda Research Support; Astellas Research Support; Scholarship donations from Chugai Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Daiichi Sankyo Co., Ltd. We would like to thank Editage ( www.editage.com ) for English language editing.
Publisher Copyright:
© 2020 Japan Society of Obstetrics and Gynecology
PY - 2020/9/1
Y1 - 2020/9/1
N2 - A hypertensive disorder of pregnancy (HDP) is defined as hypertension emerging after 20 weeks of gestation and resolving up to 12 weeks post-partum, and occurs in about 5% of all pregnancies. Complications associated with HDP have poor prognoses, and maternal deaths attributable to HDP are predicted to exceed 70 000 per year worldwide. Understanding the pathogenesis and risk factors of hypertensive disorders of pregnancy is important, and they are often investigated in observational studies. Given that therapeutic interventions cannot be controlled in observed studies, it is necessary to interpret which factors correspond to exposure and which factors correspond to confounding and intermediate factors in each study. From the Babies and their parents' longitudinal observation in the Suzuki Memorial Hospital on Intrauterine period study, blood pressure in early pregnancy was not only predictive of a child's birthweight, but the trajectory was also associated with the birthweight. From the larger-scale birth cohort studies currently conducted in Japan will provide the novel potential risk factors of hypertensive disorders of pregnancy and preventive strategies of them. In Japan, observational or intervention studies are just beginning to emerge. The continuation of both a distinctive cohort and a large cohort is needed, and the development of good quality intervention trials based on the results of observational studies is important.
AB - A hypertensive disorder of pregnancy (HDP) is defined as hypertension emerging after 20 weeks of gestation and resolving up to 12 weeks post-partum, and occurs in about 5% of all pregnancies. Complications associated with HDP have poor prognoses, and maternal deaths attributable to HDP are predicted to exceed 70 000 per year worldwide. Understanding the pathogenesis and risk factors of hypertensive disorders of pregnancy is important, and they are often investigated in observational studies. Given that therapeutic interventions cannot be controlled in observed studies, it is necessary to interpret which factors correspond to exposure and which factors correspond to confounding and intermediate factors in each study. From the Babies and their parents' longitudinal observation in the Suzuki Memorial Hospital on Intrauterine period study, blood pressure in early pregnancy was not only predictive of a child's birthweight, but the trajectory was also associated with the birthweight. From the larger-scale birth cohort studies currently conducted in Japan will provide the novel potential risk factors of hypertensive disorders of pregnancy and preventive strategies of them. In Japan, observational or intervention studies are just beginning to emerge. The continuation of both a distinctive cohort and a large cohort is needed, and the development of good quality intervention trials based on the results of observational studies is important.
KW - cardiovascular
KW - fetal growth restriction
KW - pre-eclampsia/eclampsia
KW - renal and hypertension
KW - research design/epidemiology and statistics
UR - http://www.scopus.com/inward/record.url?scp=85088527726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088527726&partnerID=8YFLogxK
U2 - 10.1111/jog.14383
DO - 10.1111/jog.14383
M3 - Article
C2 - 32715567
AN - SCOPUS:85088527726
SN - 1341-8076
VL - 46
SP - 1672
EP - 1677
JO - Journal of Obstetrics and Gynaecology Research
JF - Journal of Obstetrics and Gynaecology Research
IS - 9
ER -